Literature DB >> 2060676

Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy.

M T Watts1, M Greaves, I G Rennie, L G Clearkin.   

Abstract

The involvement of antiphospholipid antibodies in the mediation of acute anterior ischaemic optic neuropathy (AION) was studied, in the light of recent associations between these autoantibodies and other vascular events. A strong association between IgG anticardiolipin antibodies and AION secondary to biopsy proven giant cell arteritis was identified, which did not exist with the 'non-arteritic', biopsy negative form of AION. The possible implications of this finding on the aetiology, diagnosis, and treatment of giant cell arteritis are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060676     DOI: 10.1038/eye.1991.15

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  6 in total

1.  Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS.

Authors:  F Y Demirci; R Küçükkaya; K Akarçay; N Kir; T Atamer; H Demirci; E Ongör
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study.

Authors:  C D Kalogeropoulos; P Spyrou; M I Stefaniotou; E E Tsironi; A A Drosos; K G Psilas
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

3.  Hypercoagulable states in patients with retinal venous occlusion.

Authors:  A M Abu El-Asrar; A G Abdel Gader; S Al-Amro; A K Al-Momen
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

Review 4.  Optic neuropathy in the "primary" antiphospholipid syndrome: report of a case and review of the literature.

Authors:  S Reino; F J Muñoz-Rodriguez; R Cervera; G Espinosa; J Font; M Ingelmo
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 5.  Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes.

Authors:  R M McLean; T P Greco
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

Review 6.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.